Treatment of Morbihan disease
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCIScopus
- 저널 순위
- Scopus Q4KCI Q2
- 저널
- Archives of Craniofacial Surgery22(3) · pp.131 · 2021
- 피인용
- Scopus 14KCI 1
- FWCI (Scopus)
- 1.82
- ISSN
- 2287-1152
저자
- 김주형제1저자교신저자Department of Plastic and Reconstructive Surgery, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
초록
Morbihan disease (MD) is a rare condition that involves rosaceous lymphedema or erythematous lymphedema of the middle and upper thirds of the face. It typically affects the periorbital region, forehead, glabella, nose, and cheeks. The etiology of MD remains unclear, and its diagnosis is challenging. MD often tends to be unresponsive to therapies commonly used to treat rosacea, including corticosteroids, isotretinoin, and antibiotics. Surgical treatments have therefore been attempted, but most cases showed unsatisfactory responses. These problems could have resulted from an incorrect recognition and interpretation of the pathophysiology of MD and inaccurate planning of the operation, resulting in recurrence or exacerbation of edema.
키워드
식별자
- Scopus EID
- 2-s2.0-85110446590
- KCI
- ART002725503



로그인
연구물 목록으로